Vaccines

06 Dec 2010 Generex Presents New Positive AE37 Phase II Breast Cancer Vaccine Data
06 Dec 2010 Fraunhofer USA CMB Initiates Phase I Clinical Trial for Avian (H5N1) Influenza Vaccine
06 Dec 2010 GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
03 Dec 2010 Microbix Biosystems Forms Influenza Vaccine Subsidiary, Crucible International Biotechnologies
02 Dec 2010 Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
30 Nov 2010 Mymetics HIV Vaccine Shows Strong Preliminary Phase I Data
30 Nov 2010 NanoBio Receives $6 Million to Develop an Intranasal Vaccine for Respiratory Syncytial Virus (RSV)
30 Nov 2010 Argos Therapeutics Initiates Dosing of Patients in Phase 2b Clinical Trial of Arcelis Personalized Immunotherapy for Treatment of HIV Patients
29 Nov 2010 Sanofi Pasteur Starts a Phase II Vaccine Trial for Primary Prevention of Clostridium Difficile
25 Nov 2010 VIVALIS : ACHIEVES A SIGNIFICANT MILESTONE WITH THE ACCEPTANCE OF AN INVESTIGATIONAL NEW DRUG FILING (IND) FOR A CANDIDATE INFLUENZA VACCINE USING EB66 CELL-BASED TECHNOLOGY
24 Nov 2010 Advaxis India Cervix Cancer Trial Begins Dosing
22 Nov 2010 Celldex Therapeutics Reports Positive Results from Rindopepimut Phase 2 Brain Cancer Study at SNO 2010
18 Nov 2010 Further Analysis of Vacc-4x Phase IIb Study Shows a Statistically Significant Reduction in Viral Load Over Placebo -- Previous Decision to Put Vacc-4x on Hold Has Been Reversed
18 Nov 2010 FDA Advisory Committee Supports Approval of Merck & Co.'s GARDASIL(R) for Prevention of Anal Cancer and AIN in both Men and Women
17 Nov 2010 Inovio Pharmaceuticals’ HIV DNA Vaccine Achieves Strong T-Cell Immune Responses in Phase I Human Trial
17 Nov 2010 Immunovaccine Inc. Announces Phase I/II Clinical Plan for DPX-Survivac to Target Ovarian Cancer
12 Nov 2010 London Genetics and Astrimmune to Collaborate on Cancer Vaccine
11 Nov 2010 Pevion's Breakthrough Candida Vaccine Demonstrates Safety and Immunogenicity in Phase I Clinical Study
10 Nov 2010 Diamyd Completes Screening for US Phase III Study
09 Nov 2010 Nabi Biopharmaceuticals Completes Enrollment of Second NicVAX Phase III Clinical Trial
08 Nov 2010 Advaxis Enters into Collaboration with the University of British Columbia
05 Nov 2010 New clinical study started with the nicotine vaccine NIC002
04 Nov 2010 Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development
04 Nov 2010 Novel Recombinant Chikungunya Virus Vaccine Shown to be Safe and Effective in Multiple Animal Models
02 Nov 2010 Soligenix Announces Completion of Enrollment and Preliminary Safety Results of a Phase 1B Clinical Trial for RiVax

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top